MESCIUS USA, Inc. (formerly GrapeCity), a global provider of award-winning enterprise software development tools, is pleased to announce that it has been recognized as the 2025 number two publisher ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI® with one-third ...

At ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg ...

Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Late-breaking data ...

Using novel meta-analytical techniques (ie, model-based dose-response network meta-analysis under a Bayesian framework) and evidence from existing randomised controlled trials ... physical activity ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. I’ve been testing and reviewing the best TVs for nearly 30 years and have witnessed ...

Stool consistency was described by patients according to the Bristol Stool Chart. Adult patients (≥18 ... consistent finding in randomised, controlled trials,5,9 independent of whether high-dose ...

All centres from the EULAR Scleroderma Trials and Research group were invited to submit and select clinical questions concerning SSc treatment using a Delphi approach. Accordingly, 46 clinical ...

After you're approved for Medicaid or CHIP, you must pick a health plan. We will send you a packet in the mail when it's time to choose a health plan. The packet will include facts about each health ...

Copyright: © 2015 Elsevier Ltd. Published by Elsevier Ltd.